Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
Journal website https://www.gastrores.org |
Case Report
Volume 15, Number 1, February 2022, pages 33-38
Polygenic Infantile Juvenile Polyposis Syndrome Managed With Sirolimus and Endoscopic Polypectomy
Figures
Tables
Age (months) | Type of endoscopy | No. of upper GI polyps removed | No. of deep small bowel polyps removed | No. of lower GI polyps removed |
---|---|---|---|---|
aSirolimus was started. GI: gastrointestinal. | ||||
8 | Flexible sigmoidoscopy | Region not evaluated | Region not evaluated | 0 (due to poor bowel preparation) |
9 | Colonoscopy | Region not evaluated | Region not evaluated | 20 |
9 | Colonoscopy | Region not evaluated | Region not evaluated | 7 |
10 | Colonoscopy | Region not evaluated | Region not evaluated | 12 |
12 | Upper endoscopy + colonoscopy | 15 | Region not evaluated | 10 |
13 | Colonoscopy | Region not evaluated | Region not evaluated | 50 |
14 | Upper endoscopy + enteroscopy | 10 + (undisclosed No. of) duodenal polyps | 50 | Region not evaluated |
14a | Start sirolimus | |||
19 | Upper endoscopy + colonoscopy | 9 | Region not evaluated | 26 |
24 | Upper endoscopy + colonoscopy | 7 | Region not evaluated | 48 |
33 | Upper endoscopy + colonoscopy | 10 | Region not evaluated | 84 |
39 | Colonoscopy | Region not evaluated | Region not evaluated | 103 |
46 | Upper endoscopy + colonoscopy | 2 | Region not evaluated | 52 |
57 | Colonoscopy | Region not evaluated | Region not evaluated | 52 |
67 | Upper endoscopy + colonoscopy | 4 | Region not evaluated | 68 |
Pre-sirolimus | Post-sirolimus | % reduction | |
---|---|---|---|
Months of disease course | 6.3 | 55.03 | |
No. of upper polyps resected per year | 47.62 | 7.41 | 84.44% |
No. of lower polyps resected per year | 188.57 | 101.18 | 46.34% |
No. of upper endoscopies per year | 1.9 | 1.09 | 42.63% |
No. of lower endoscopies per year | 9.52 | 1.53 | 83.93% |